Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life.

Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of... To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of clinical oncology : official journal of the American Society of Clinical Oncology Pubmed

Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology , Volume 20 (20): -4233 – Oct 24, 2002

Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life.


Abstract

To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL).

Loading next page...
 
/lp/pubmed/chronic-arm-morbidity-after-curative-breast-cancer-treatment-Vli0vX02i8

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0732-183X
DOI
10.1200/JCO.2002.09.018
pmid
12377968

Abstract

To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL).

Journal

Journal of clinical oncology : official journal of the American Society of Clinical OncologyPubmed

Published: Oct 24, 2002

There are no references for this article.